P04.13 Newborn affected by maternal use of anticonvulsants

Billable / valid for submission ICD10CM Release FY2026

Version history

Related codes in P04

• P04 Newborn affected by noxious substances transmitted via placenta or breast milk
• P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
• P04.1 Newborn affected by other maternal medication
• P04.11 Newborn affected by maternal antineoplastic chemotherapy
• P04.12 Newborn affected by maternal cytotoxic drugs
• P04.14 Newborn affected by maternal use of opiates
• P04.15 Newborn affected by maternal use of antidepressants
• P04.16 Newborn affected by maternal use of amphetamines
• P04.17 Newborn affected by maternal use of sedative-hypnotics
• P04.18 Newborn affected by other maternal medication
• P04.19 Newborn affected by maternal use of unspecified medication
• P04.1A Newborn affected by maternal use of anxiolytics
• P04.2 Newborn affected by maternal use of tobacco
• P04.3 Newborn affected by maternal use of alcohol
• P04.4 Newborn affected by maternal use of drugs of addiction
• P04.40 Newborn affected by maternal use of unspecified drugs of addiction
• P04.41 Newborn affected by maternal use of cocaine
• P04.42 Newborn affected by maternal use of hallucinogens
• P04.49 Newborn affected by maternal use of other drugs of addiction
• P04.5 Newborn affected by maternal use of nutritional chemical substances

All P04 codes →